Literature DB >> 10588203

Direct coronary stenting without predilation.

C Briguori1, I Sheiban, J De Gregorio, A Anzuini, M Montorfano, P Pagnotta, F Marsico, F Leonardo, C Di Mario, A Colombo.   

Abstract

OBJECTIVES: Coronary stenting is the primary therapeutic option for percutaneous treatment of many coronary lesions, after the risk of subacute stent thrombosis and bleeding complications has been reduced by improved antithrombotic regimens and high pressure stent expansion.
BACKGROUND: Direct stent implantation (without predilation) has been considered a promising new technique that may reduce the procedure time, radiation exposure time and cost.
METHODS: After having reviewed all cases of stent implantation from February to June 1998 (n = 585), 185 (32%) of these patients were retrospectively considered candidates for direct stent implantation without predilation, according to prespecified criteria (i.e., absence of severe coronary calcifications and/or tortuosity of the lesion or the segment proximal to the lesion). By operator preference, direct coronary stent implantation was actually attempted in 123 (21%) of the 585 patients (100 men, 60 +/- 10 years old) on 123 lesions. The impact of direct stenting in terms of cost, procedure time, radiation exposure time and amount of contrast dye used was assessed by comparing the two groups of patients who underwent single-vessel stenting without (n = 69) and with (n = 46) predilation.
RESULTS: Direct stenting was successful in 118 patients (96%). No acute or subacute complications occurred in these patients. Procedure time, radiation exposure time and cost were significantly lower in the group of patients who had single-vessel direct versus conventional stenting (45 +/- 31 vs. 64 +/- 46 min, 12 +/- 9 vs. 16 +/- 10 min and 1,305 +/- 363 vs. 2,210 +/- 803 Euro, respectively; p < 0.05 for all).
CONCLUSIONS: Direct stenting without predilation in selected lesions seems to be a safe and successful procedure that provides a way to contain cost and to shorten radiation exposure time.

Entities:  

Mesh:

Year:  1999        PMID: 10588203     DOI: 10.1016/s0735-1097(99)00453-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  New developments in endovascular interventions for extracranial carotid stenosis.

Authors:  W A Tan; C R Jarmolowski; L R Wechsler; M H Wholey
Journal:  Tex Heart Inst J       Date:  2000

2.  Managing a complication after direct stenting: removal of a maldeployed stent with rotational atherectomy.

Authors:  M Herzum; R Cosmeleata; B Maisch
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

3.  Clinical and angiographic outcome after conventional angioplasty with optional stent implantation compared with direct stenting without predilatation.

Authors:  S Miketic; J Carlsson; U Tebbe
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

4.  Randomised comparison of coronary stenting with and without balloon predilatation in selected patients.

Authors:  H Le Breton; J Boschat; P Commeau; P Brunel; M Gilard; C Breut; O Bar; P Geslin; A Tirouvanziam; L Maillard; B Moquet; P Barragan; P Dupouy; G Grollier; J Berland; P Druelles; R Rihani; B Huret; C Leclercq; M Bedossa
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

5.  Prognostic implication of cardiac troponin T increase following stent implantation.

Authors:  J Herrmann; C Von Birgelen; M Haude; L Volbracht; N Malyar; H Eggebrecht; T F M Konorza; D Baumgart; R Erbel
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

6.  Direct coronary stenting in reducing radiation and radiocontrast consumption.

Authors:  Jasmin Caluk; Enes Osmanovic; Fahir Barakovic; Zumreta Kusljugic; Ibrahim Terzic; Selma Caluk; Amela Sofic
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

7.  In-hospital and mid-term adverse clinical outcomes of a direct stenting strategy versus stenting after pre-dilatation for the treatment of coronary artery lesions.

Authors:  M Alidoosti; M Salarifar; S E Kassaian; A M Zeinali; M S Fathollahi; M R Dehkordi
Journal:  Cardiovasc J Afr       Date:  2008 Nov-Dec       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.